ZNTL Earnings

Quarterly EPS
$-0.56
Q3 2024
$-0.67
Q4 2024
$-0.67
Q1 2025
$-0.37
Q2 2025
$-0.37
Q3 2025
$-0.49
Q4 2025
$-0.50
Q1 2026
$-0.59
Q2 2026
Latest RevenueN/A
Latest Net Income-42286000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$0.590-42286000-59.5%
Q1 2026-$0.500-35352000+25.4%
Q4 2025-$0.490-35216000-100.0%+26.9%
Q3 2025-$0.370-26691000+33.9%
Q2 2025-$0.370-26874000+70.2%
Q1 2025-$0.670-48279000-100.0%-578.6%
Q4 2024-$0.6726.9M-47472000+22.1%
Q3 2024-$0.560-40158000+29.1%
Q2 2024-$1.240-88277000
Q1 2024$0.1440.6M10.0M
Q4 2023-$0.860-60939000
Q3 2023-$0.790-55540000
Zentalis Pharmaceuticals (ZNTL) — Earnings